IDH1 and acute myeloid leukemia: Mutations in IDH1/2 occur frequently in acute myeloid leukemia (AML) and gliomas and are neomorphic mutations that lead to the aberrant production of 2-hydroxyglutarate (2-HG) while consuming NADPH (122).